AAAAAA
Results: 1-25/28
Authors:
Himmelmann, A
Ruegg, R
Fehr, J
Citation: A. Himmelmann et al., Familial persistent polyclonal B-cell lymphocytosis, LEUK LYMPH, 41(1-2), 2001, pp. 157
Authors:
Hansson, L
Hedner, T
Himmelmann, A
Citation: L. Hansson et al., The lower the better - PROGRESS of the concept, BLOOD PRESS, 10(3), 2001, pp. 122-123
Authors:
Himmelmann, A
Hansson, L
Hedner, T
Citation: A. Himmelmann et al., The Captopril Prevention Project, further analyses on left ventricular hypertrophy and diabetes, BLOOD PRESS, 10(2), 2001, pp. 60-61
Authors:
Hedner, T
Himmelmann, A
Hansson, L
Citation: T. Hedner et al., The discovery of dopamine rewarded - The Nobel Prize in Physiology and Medicine 2000, BLOOD PRESS, 10(1), 2001, pp. 4-5
Authors:
Himmelmann, A
Keinanen-Kiukaanniemi, S
Wester, A
Redon, J
Asmar, R
Hedner, T
Citation: A. Himmelmann et al., The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension, BLOOD PRESS, 10(1), 2001, pp. 43-51
Authors:
Himmelmann, A
Gautschi, O
Nawrath, M
Bolliger, U
Fehr, J
Stahel, RA
Citation: A. Himmelmann et al., Persistent polyclonal B-cell lymphocytosis is an expansion of functional IgD(+)CD27(+) memory B cells, BR J HAEM, 114(2), 2001, pp. 400-405
Authors:
Jafar, TH
Schmid, CH
Landa, M
Giatras, I
Toto, R
Remuzzi, G
Maschio, G
Brenner, BM
Kamper, A
Zucchelli, P
Becker, G
Himmelmann, A
Bannister, K
Landais, P
Shahinfar, S
de Jong, PE
de Zeeuw, D
Lau, J
Levey, AS
Citation: Th. Jafar et al., Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease - A meta-analysis of patient-level data, ANN INT MED, 135(2), 2001, pp. 73-87
Authors:
Jacobsson, F
Himmelmann, A
Bergbrant, A
Svensson, A
Mannheimer, C
Citation: F. Jacobsson et al., The effect of transcutaneous electric nerve stimulation in patients with therapy-resistant hypertension, J HUM HYPER, 14(12), 2000, pp. 795-798
Authors:
Hedner, T
Himmelmann, A
Hansson, L
Citation: T. Hedner et al., Assessment of risks of hypertension and benefits of treatment - a difficult matter, BLOOD PRESS, 9(6), 2000, pp. 307-308
Authors:
Hansson, L
Hedner, T
Himmelmann, A
Citation: L. Hansson et al., Postmenopausal hormone replacement therapy and hypertension, BLOOD PRESS, 9(5), 2000, pp. 245-245
Authors:
Himmelmann, A
Hedner, T
Hansson, L
Citation: A. Himmelmann et al., Blood pressure measurement - Bringing it all back home, BLOOD PRESS, 9(4), 2000, pp. 180-181
Authors:
Hedner, T
Hansson, L
Himmelmann, A
Citation: T. Hedner et al., Blood pressure @ Internet-www.bloodpressure.nu, BLOOD PRESS, 9(2-3), 2000, pp. 68-70
Authors:
Hedner, T
Hansson, L
Himmelmann, A
Citation: T. Hedner et al., Endothelial dysfunction - A challenge for hypertension research, BLOOD PRESS, 9(1), 2000, pp. 2-3
Authors:
Wennerstrom, M
Hansson, S
Hedner, T
Himmelmann, A
Jodal, U
Citation: M. Wennerstrom et al., Ambulatory blood pressure 16-26 years after the first urinary tract infection in childhood, J HYPERTENS, 18(4), 2000, pp. 485-491
Authors:
Himmelmann, A
Bortoluzzi, L
Jansen, S
Fehr, J
Citation: A. Himmelmann et al., Frequency of HFE gene mutations and genotype-phenotype correlations in Swiss patients with hereditary haemochromatosis, SCHW MED WO, 130(31-32), 2000, pp. 1112-1119
Authors:
Lorenz, E
Hagen, B
Himmelmann, A
Kjorstadt, K
Onsrud, M
Tingulstad, S
Gundersen, G
Citation: E. Lorenz et al., A phase II study of biweekly administration of paclitaxel in patients withrecurrent epithelial ovarian cancer, INT J GYN C, 9(5), 1999, pp. 373-376
Authors:
Himmelmann, A
Citation: A. Himmelmann, New information on the role of beta-blockers in cardiac therapy, CARDIO DRUG, 13(6), 1999, pp. 469-477
Authors:
Hedner, T
Himmelmann, A
Hansson, L
Citation: T. Hedner et al., Awareness, management and follow-up of lipoprotein disturbances in hypertension, BLOOD PRESS, 8(5-6), 1999, pp. 251-252
Authors:
Himmelmann, A
Citation: A. Himmelmann, Hypertension: an important precursor of heart failure, BLOOD PRESS, 8(5-6), 1999, pp. 253-260
Authors:
Hansson, L
Himmelmann, A
Hedner, T
Citation: L. Hansson et al., Hypertension and dementia: Can antihypertensive treatment preserve cognitive function?, BLOOD PRESS, 8(4), 1999, pp. 196-197
Authors:
Himmelmann, A
Hansson, L
Hedner, T
Citation: A. Himmelmann et al., Blood pressure and coronary heart disease, BLOOD PRESS, 8(3), 1999, pp. 132-133
Authors:
Hedner, T
Himmelmann, A
Hansson, L
Citation: T. Hedner et al., A remarkable remedy receives nobel prize recognition, BLOOD PRESS, 8(2), 1999, pp. 68-69
Authors:
Hansson, L
Hedner, T
Himmelmann, A
Citation: L. Hansson et al., Alcohol and hypertension - How are they linked?, BLOOD PRESS, 8(1), 1999, pp. 3-4
Authors:
Hansson, L
Hedner, T
Himmelmann, A
Citation: L. Hansson et al., The 1999 WHOISH Guidelines for the Management of Hypertension - New targets, new treatment and a comprehensive approach to total cardiovascular risk reduction, BLOOD PRESS, 8, 1999, pp. 3-5
Authors:
Hedner, T
Himmelmann, A
Citation: T. Hedner et A. Himmelmann, The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension, J HYPERTENS, 17(1), 1999, pp. 129-136